Potential mechanisms of aberrant DNA hypomethylation on the X chromosome in uterine leiomyomas

Journal of Reproduction and Development

Volumn 60, Issue 1, 2014, Pages 47-54

  Sato, Shun ^a   Maekawa, Ryo ^a   Yamagata, Yoshiaki ^a   Asada, Hiromi ^a   Tamura, Isao ^a   Lee, Lifa ^a   Okada, Maki ^a   Tamura, Hiroshi ^a   Sugino, Norihiro ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

DNA methylation; Uterine leiomyomas; X chromosome; X chromosome inactivation

Indexed keywords

ADULT; ARTICLE; DNA METHYLATION; FEMALE; GENETICS; HUMAN; LEIOMYOMA; METABOLISM; MIDDLE AGED; MUTATION; MYOMETRIUM; PATHOLOGY; UPREGULATION; UTERUS CANCER;

ADULT; DNA METHYLATION; FEMALE; HUMANS; LEIOMYOMA; MIDDLE AGED; MUTATION; MYOMETRIUM; UP-REGULATION; UTERINE NEOPLASMS;

EID: 84897811666     PISSN: 09168818     EISSN: 13484400     Source Type: Journal    
DOI: 10.1262/jrd.2013-095     Document Type: Article

References (41)

1. Stewart EA. Uterine fibroids. Lancet 2001; 357: 293-298. [Medline] [CrossRef]
2. Bajekal N, Li TC. Fibroids, infertility and pregnancy wastage. Hum Reprod Update 2000; 6: 614-620. [Medline] [CrossRef]
3. Chiaffarino F, Parazzini F, La Vecchia C, Chatenoud L, Di Cintio E, Marsico S. Diet and uterine myomas. Obstet Gynecol 1999; 94: 395-398. [Medline] [CrossRef]
4. Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practicebased case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol 2001; 153: 1-10. [Medline] [CrossRef]
5. Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practicebased case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol 2001; 153: 11-19. [Medline] [CrossRef]
6. Eskenazi B, Warner M, Samuels S, Young J, Gerthoux PM, Needham L, Patterson D, Olive D, Gavoni N, Vercellini P, Mocarelli P. Serum dioxin concentrations and risk of uterine leiomyoma in the Seveso Women's Health Study. Am J Epidemiol 2007; 166: 79-87. [Medline] [CrossRef]
7. Shiota K, Yanagimachi R. Epigenetics by DNA methylation for development of normal and cloned animals. Differentiation 2002; 69: 162-166. [Medline] [CrossRef]
8. Yagi S, Hirabayashi K, Sato S, Li W, Takahashi Y, Hirakawa T, Wu G, Hattori N, Ohgane J, Tanaka S, Liu XS, Shiota K. DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) in mouse promoter regions demonstrating tissue-specific gene expression. Genome Res 2008; 18: 1969-1978. [Medline] [CrossRef]
9. Davis CD, Uthus EO. Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats. J Nutr 2003; 133: 2907-2914. [Medline]
10. Hatziapostolou M, Iliopoulos D. Epigenetic aberrations during oncogenesis. Cell Mol Life Sci 2011; 68: 1681-1702. [Medline] [CrossRef]
11. Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009; 33: 3-11. [Medline] [CrossRef]
12. Iwatani M, Ikegami K, Kremenska Y, Hattori N, Tanaka S, Yagi S, Shiota K. Dimethyl sulfoxide has an impact on epigenetic profile in mouse embryoid body. Stem Cells 2006; 24: 2549-2556. [Medline] [CrossRef]
13. Waki H, Yamauchi T, Kadowaki T. The epigenome and its role in diabetes. Curr Diab Rep 2012; 12: 673-685. [Medline] [CrossRef]
14. Wu Q, Ohsako S, Ishimura R, Suzuki JS, Tohyama C. Exposure of mouse preimplantation embryos to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters the methylation status of imprinted genes H19 and Igf2. Biol Reprod 2004; 70: 1790-1797. [Medline] [CrossRef]
15. Yamagata Y, Maekawa R, Asada H, Taketani T, Tamura I, Tamura H, Ogane J, Hattori N, Shiota K, Sugino N. Aberrant DNA methylation status in human uterine leiomyoma. Mol Hum Reprod 2009; 15: 259-267. [Medline] [CrossRef]
16. Asada H, Yamagata Y, Taketani T, Matsuoka A, Tamura H, Hattori N, Ohgane J, Shiota K, Sugino N. Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation. Mol Hum Reprod 2008; 14: 539-545. [Medline] [CrossRef]
17. Maekawa R, Yagi S, Ohgane J, Yamagata Y, Asada H, Tamura I, Sugino N, Shiota K. Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma. J Reprod Dev 2011; 57: 604-612. [Medline] [CrossRef]
18. Maekawa R, Sato S, Yamagata Y, Asada H, Tamura I, Lee L, Okada M, Tamura H, Takaki E, Nakai A, Sugino N. Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas. PLoS One 2013; 8: e66632. [Medline] [CrossRef]
19. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9: 2395-2402. [Medline] [CrossRef]
20. Igarashi S, Suzuki H, Niinuma T, Shimizu H, Nojima M, Iwaki H, Nobuoka T, Nishida T, Miyazaki Y, Takamaru H, Yamamoto E, Yamamoto H, Tokino T, Hasegawa T, Hirata K, Imai K, Toyota M, Shinomura Y. A novel correlation between LINE-1 hypomethylation and the malignancy of gastrointestinal stromal tumors. Clin Cancer Res 2010; 16: 5114-5123. [Medline] [CrossRef]
21. Camargo M, Wang N. Cytogenetic evidence for the absence of an inactivated X chromosome in a human female (XX) breast carcinoma cell line. Hum Genet 1980; 55: 81-85. [Medline] [CrossRef]
22. Kawakami T, Zhang C, Taniguchi T, Kim CJ, Okada Y, Sugihara H, Hattori T, Reeve AE, Ogawa O, Okamoto K. Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene 2004; 23: 6163-6169. [Medline] [CrossRef]
23. Sirchia SM, Ramoscelli L, Grati FR, Barbera F, Coradini D, Rossella F, Porta G, Lesma E, Ruggeri A, Radice P, Simoni G, Miozzo M. Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. Cancer Res 2005; 65: 2139-2146. [Medline] [CrossRef]
24. Arthold S, Kurowski A, Wutz A. Mechanistic insights into chromosome-wide silencing in X inactivation. Hum Genet 2011; 130: 295-305. [Medline] [CrossRef]
25. Escamilla-Del-Arenal M, da Rocha ST, Heard E. Evolutionary diversity and developmental regulation of X-chromosome inactivation. Hum Genet 2011; 130: 307-327. [Medline] [CrossRef]
26. Agrelo R, Souabni A, Novatchkova M, Haslinger C, Leeb M, Komnenovic V, Kishimoto H, Gresh L, Kohwi-Shigematsu T, Kenner L, Wutz A. SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev Cell 2009; 16: 507-516. [Medline] [CrossRef]
27. Blewitt ME, Gendrel AV, Pang Z, Sparrow DB, Whitelaw N, Craig JM, Apedaile A, Hilton DJ, Dunwoodie SL, Brockdorff N, Kay GF, Whitelaw E. SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation. Nat Genet 2008; 40: 663-669. [Medline] [CrossRef]
28. Gendrel AV, Apedaile A, Coker H, Termanis A, Zvetkova I, Godwin J, Tang YA, Huntley D, Montana G, Taylor S, Giannoulatou E, Heard E, Stancheva I, Brockdorff N. Smchd1-dependent and-independent pathways determine developmental dynamics of CpG island methylation on the inactive X chromosome. Dev Cell 2012; 23: 265-279. [Medline] [CrossRef]
29. Hasegawa Y, Brockdorff N, Kawano S, Tsutui K, Nakagawa S. The matrix protein hnRNP U is required for chromosomal localization of Xist RNA. Dev Cell 2010; 19: 469-476. [Medline] [CrossRef]
30. Mäkinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, Gentile M, Yan J, Enge M, Taipale M, Aavikko M, Katainen R, Virolainen E, Böhling T, Koski TA, Launonen V, Sjöberg J, Taipale J, Vahteristo P, Aaltonen LA. MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas. Science 2011; 334: 252-255. [Medline] [CrossRef]
31. Suzuki M, Sato S, Arai Y, Shinohara T, Tanaka S, Greally JM, Hattori N, Shiota K. A new class of tissue-specifically methylated regions involving entire CpG islands in the mouse. Genes Cells 2007; 12: 1305-1314. [Medline] [CrossRef]
32. Kumaki Y, Oda M, Okano M. QUMA: quantification tool for methylation analysis. Nucleic Acids Res 2008; 36: W170-W175. [Medline] [CrossRef]
33. Ono M, Qiang W, Serna VA, Yin P, Coon V JS, Navarro A, Monsivais D, Kakinuma T, Dyson M, Druschitz S, Unno K, Kurita T, Bulun SE. Role of stem cells in human uterine leiomyoma growth. PLoS One 2012; 7: e36935. [Medline] [CrossRef]
34. Choufani S, Shapiro JS, Susiarjo M, Butcher DT, Grafodatskaya D, Lou Y, Ferreira JC, Pinto D, Scherer SW, Shaffer LG, Coullin P, Caniggia I, Beyene J, Slim R, Bartolomei MS, Weksberg R. A novel approach identifies new differentially methylated regions (DMRs) associated with imprinted genes. Genome Res 2011; 21: 465-476. [Medline] [CrossRef]
35. Woodfine K, Huddleston JE, Murrell A. Quantitative analysis of DNA methylation at all human imprinted regions reveals preservation of epigenetic stability in adult somatic tissue. Epigenetics Chromatin 2011; 4: 1. [Medline] [CrossRef]
36. Schulz R, Woodfine K, Menheniott TR, Bourc'his D, Bestor T, Oakey RJ. WAMIDEX: a web atlas of murine genomic imprinting and differential expression. Epigenetics 2008; 3: 89-96. [Medline] [CrossRef]
37. Arslan AA, Gold LI, Mittal K, Suen TC, Belitskaya-Levy I, Tang MS, Toniolo P. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 2005; 20: 852-863. [Medline] [CrossRef]
38. Gross KL, Morton CC. Genetics and the development of fibroids. Clin Obstet Gynecol 2001; 44: 335-349. [Medline] [CrossRef]
39. Tao KP, Fong SW, Lu Z, Ching YP, Chan KW, Chan SY. TSPYL2 is important for G1 checkpoint maintenance upon DNA damage. PLoS One 2011; 6: e21602. [Medline] [CrossRef]
40. Pirruccello M, De Camilli P. Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL. Trends Biochem Sci 2012; 37: 134-143. [Medline] [CrossRef]
41. Kagami M, O'Sullivan MJ, Green AJ, Watabe Y, Arisaka O, Masawa N, Matsuoka K, Fukami M, Matsubara K, Kato F, Ferguson-Smith AC, Ogata T. The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers. PLoS Genet 2010; 6: e1000992. [Medline] [CrossRef]